In the present study, we showed that IOE treatment has similar effects to metformin to ameliorate insulin resistance, glucose intolerance, and dyslipidemia in mice, probably through activation of the insulin signaling pathway and upregulation of GLUT4 expression. Here, SLC2A4 is linked to Insulin resistance.